BELITE BIO, INC·4

May 6, 4:15 PM ET

MATA NATHAN L. 4

4 · BELITE BIO, INC · Filed May 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Belite Bio (BLTE) CSO Nathan Mata Sells Shares

What Happened Nathan L. Mata, Chief Scientific Officer of Belite Bio, sold a total of 1,000 American Depositary Shares (ADSs) in multiple open-market transactions on May 5, 2026, generating roughly $155,503 in proceeds. The sales were executed in six tranches: 120 @ $153.92 ($18,471); 363 @ $154.44 ($56,063); 173 @ $155.48 ($26,898); 121 @ $156.53 ($18,940); 155 @ $157.29 ($24,380); and 68 @ $158.11 ($10,751). Each ADS represents one ordinary share (footnote F1).

Key Details

  • Transaction date: May 5, 2026 (filed May 6, 2026).
  • Transaction type/code: Open-market sales (S).
  • Total shares sold: 1,000 ADSs for total proceeds of about $155,503.
  • Per-tranche details: 120 @ $153.92; 363 @ $154.44; 173 @ $155.48; 121 @ $156.53; 155 @ $157.29; 68 @ $158.11 (values above as reported).
  • Footnotes: Sales were made pursuant to a Rule 10b5‑1 trading plan adopted 12/10/2025 (F2). Report includes weighted-average price groupings and ranges per footnotes F3–F7; the filer can provide exact per-price breakdowns on request.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing timeliness: Reported the day after the transactions (appears timely, not marked late).

Context A 10b5‑1 plan allows insiders to sell shares on a preset schedule or formula and is commonly used to avoid trading while in possession of material nonpublic information; it does not itself indicate the insider’s current view of the company. Sales (code S) are routine insider disclosures—factual reporting of disposition rather than evidence of motive.

Insider Transaction Report

Form 4
Period: 2026-05-05
MATA NATHAN L.
Chief Scientific Officer
Transactions
  • Sale

    American depositary share

    [F1][F2][F3]
    2026-05-05$153.92/sh120$18,4712,546 total
  • Sale

    American depositary share

    [F1][F2][F4]
    2026-05-05$154.44/sh363$56,0632,183 total
  • Sale

    American depositary share

    [F1][F2][F5]
    2026-05-05$155.48/sh173$26,8982,010 total
  • Sale

    American depositary share

    [F1][F2][F6]
    2026-05-05$156.53/sh121$18,9401,889 total
  • Sale

    American depositary share

    [F1][F2][F7]
    2026-05-05$157.29/sh155$24,3801,734 total
  • Sale

    American depositary share

    [F1][F2]
    2026-05-05$158.11/sh68$10,7511,666 total
Footnotes (7)
  • [F1]Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.
  • [F3]Represents the weighted average price of shares sold at prices that ranged from $153.92 to $153.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F4]Represents the weighted average price of shares sold at prices that ranged from $154.01 to $154.955. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F5]Represents the weighted average price of shares sold at prices that ranged from $155.04 to $155.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F6]Represents the weighted average price of shares sold at prices that ranged from $156.005 to $156.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F7]Represents the weighted average price of shares sold at prices that ranged from $157.035 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Signature
/s/ Nathan L. Mata|2026-05-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4